Charlotte Jane Mitchell

USPTO Granted Patents = 20 (Patent Applications = 9)

CIPO Patents = 3

EPO Patents = 9 (Patent Applications = 12)

Average Co-Inventor Count = 6.1

ph-index = 6

Forward Citations = 115(Granted Patents)

Location History:

Hertfordshire, GB (2014)
Stevenage, GB (2008 - 2021)

Company Filing History:

Glaxosmithkline Intellectual Property Development Limited

patents

Years Active: 2008-2021

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10946025 - Compounds (2021-03-16),

2. 10624898 - Compounds (2020-04-21),

3. 10383879 - Compounds (2019-08-20),

4. 10117873 - 6-amino-purin-8-one compounds (2018-11-06),

5. 9877968 - 6-amino-purin-8-one compounds (2018-01-30),

6. 9353098 - Polymorphs and salts (2016-05-31),

7. 9346806 - 6-amino-purin-8-one compounds (2016-05-24),

8. 9326987 - Indazole derivatives for use in the treatment of influenza virus infection (2016-05-03),

9. 9233962 - Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases (2016-01-12),

10. 9102668 - Polymorphs and salts (2015-08-11),

11. 8802684 - Adenine derivatives (2014-08-12),

12. 8765772 - Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases (2014-07-01),

13. 8735390 - Polymorphs and salts (2014-05-27),

14. 8609657 - Compounds (2013-12-17),

15. 8575340 - Purine derivatives and their pharmaceutical uses (2013-11-05),

Title: The Innovative Journey of Inventor Charlotte Jane Mitchell

Introduction: Charlotte Jane Mitchell, a brilliant inventor hailing from Stevenage, GB, has made remarkable contributions to the field of pharmaceuticals with 20 patents to her name.

Latest Patents: Mitchell's latest patents revolve around groundbreaking compounds aimed at inhibiting kinase activity, particularly PI3-kinase activity. These compounds, denoted by formula (I) and their salts, showcase her expertise in developing cutting-edge solutions in the realm of drug discovery.

Career Highlights: Throughout her illustrious career, Mitchell has showcased her talents at renowned companies such as GlaxoSmithKline LLC and Glaxo Group Limited. Her innovative spirit and dedication to pushing the boundaries of science have earned her accolades in the industry.

Collaborations: Alongside accomplished coworkers like Diane Mary Coe and Julie Nicole Hamblin, Mitchell has thrived in collaborative environments, fostering a culture of creativity and excellence. Together, they have worked on pioneering projects that have left a lasting impact on the field.

Conclusion: Charlotte Jane Mitchell's inventive prowess and unwavering commitment to innovation make her a trailblazer in the world of pharmaceutical inventions. Her patents stand as a testament to her ingenuity, and her collaborations have paved the way for future breakthroughs in the industry. Mitchell's legacy as a woman inventor continues to inspire generations to come.

This text is generated by artificial intelligence and may not be accurate.